BioPorto A/S (CPH: BIOPOR)
Denmark
· Delayed Price · Currency is DKK
1.850
-0.016 (-0.86%)
Sep 25, 2024, 4:59 PM CET
BioPorto Employees
BioPorto had 29 employees as of December 31, 2023. The number of employees decreased by 3 or -9.38% compared to the previous year.
Employees
29
Change (1Y)
-3
Growth (1Y)
-9.38%
Revenue / Employee
1.25M DKK
Profits / Employee
-1.85M DKK
Market Cap
792.29M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Novo Nordisk A/S | 64,319 |
Coloplast A/S | 15,692 |
Genmab A/S | 2,204 |
Zealand Pharma A/S | 253 |
Demant A/S | 21,623 |
H. Lundbeck A/S | 5,681 |
H. Lundbeck A/S | 5,681 |
ALK-Abelló A/S | 2,824 |
BioPorto News
- 7 weeks ago - BioPorto Announces Interim Results and Business Update for the Second Quarter and Six Months of Fiscal 2024 - GlobeNewsWire
- 2 months ago - BioPorto A/S to Host Second Quarter 2024 Earnings Webcast & Investor Meeting - GlobeNewsWire
- 2 months ago - BioPorto Announces NIH-Funded Study to Explore the Ability of Renal Biomarkers in Predicting Severe AKI, Advancing Beyond NLP-based AI Algorithms - GlobeNewsWire
- 2 months ago - BioPorto to Debut FDA Approved ProNephro AKI at Upcoming ADLM 2024 Clinical Lab Expo - GlobeNewsWire
- 3 months ago - BioPorto confirms market acceptance of NGAL products with US standing order. - GlobeNewsWire
- 3 months ago - Changes of number of shares and votes in BioPorto A/S - GlobeNewsWire
- 3 months ago - Private placement of 50,000,000 new shares oversubscribed - gross proceeds of DKK 81.4 million, corresponding to USD 11.7 million, to BioPorto A/S. - GlobeNewsWire
- 3 months ago - BioPorto A/S initiates a private placement of 50,000,000 new shares at market price. - GlobeNewsWire